NVAX | FY2020 Earnings Forecast for Novavax, Inc. (NASDAQ:NVAX) Issued By B.Riley Securit

Novavax, Inc.(NASDAQ:NVAX) – Investment analysts at B.Riley Securit decreased their FY2020 earnings estimates for Novavax in a report issued on Wednesday, October 21st.B.Riley Securit analyst M.Mamtani now forecasts that the biopharmaceutical company will post earnings of $14.81 per share for the year, down from their previous estimate of $25.43.B.Riley Securit also […]Stock Observer